ARCHIVES

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

This article is from The Cancer Letter archive.

Vol. 34 No. 14 | April 11, 2008

Download PDF Visit The Full Archive

Related Articles

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

Breast Cancer Risk Increases With Repeated CT Imaging

December 28, 2012

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended

February 24, 2012